The possibility of removing pharmaceuticals from aqueous solutions was examined using ibuprofen (Ibu) oxidation as an example, using in situ electrochemically synthesized ferrate(VI), a strong oxidant and coagulant, with forming of non-harmful byproducts. A solution of ibuprofen of 206 mg/L in 0.1 M phosphate buffer solution was treated with different amounts of fresh, electrochemically synthesized ferrate(VI). The changes of ibuprofen concentration in samples were determined using a UV-Vis spectrophotometer. The extent of mineralization was estimated using the changes in chemical oxygen demand (COD) values and total organic carbon (TOC) values of test samples. The largest reduction of the concentration of Ibu (41.75%) was obtained by adding 69.2 mg/L ferrate(VI) as Fe (Ibu: Fe ¼ 1: 0.34). An effective removal of ibuprofen from aqueous solutions was recorded up to 68% and it can be done by using ferrate(VI) in the ratio Ibu: Fe ¼ 1:3 as Fe. The possibility of ibuprofen removal by ferrate(VI) was confirmed by COD and TOC results, which demonstrated reduction up to 65% and 63.6%, respectively.
INTRODUCTION
Occurrences of pharmaceuticals are present in the environment, in drinking water and wastewater in significant concentrations due to use of human and veterinary medicinal products all over the world. These compounds show the highest persistence in the environment. Many studies (Paxeus ; Castiglioni et al. ; Siegrist & Joss ) indicate that the existing facilities for wastewater treatment are not effective enough to remove these micropollutants from wastewater and sludge. As a result of this, pharmaceuticals have found their way into the environment. When they enter the environment, the pharmaceutically active compounds can cause undesired effects on aquatic and terrestrial organisms (Doughton & Ternes ) . Although the concentration of the pharmaceuticals in the aqueous environment is low, a continuous and long-term intake of these pollutants may pose a potential risk for the terrestrial and aquatic organisms. For many compounds, the potential effects on humans and aquatic ecosystems are not completely understood, especially if the fact that they co-exist in mixtures with other chemicals, forming so-called chemical 'cocktails', is taken into consideration. In a toxicity study, Cleuvers () also found that the mixture of several drugs could even augment the toxicity of each drug separately. Therefore, in recent years, accumulation of pharmaceuticals in the environment is considered an emerging environmental problem.
A wide presence of pharmaceuticals in wastewater treatment plant (WWTP) effluents and in receiving aquatic environments may affect water quality and pose a potential risk to aquatic organisms and human health (Ying et al. ; Witorsch & Thomas ) . WWTP effluents have been considered an important source of micropollutants in aquatic environments. Therefore, advanced treatment technologies such as ozonation (Zimmermann et al. ) and activated carbon filtration (Nowotny et al. ) , as well as a combination of ozone and hydrogen peroxide (Klavarioti et al. ) , are required to reduce the emission of micropollutants from WWTP effluents. One of the alternative advanced oxidation technologies is ferrate (Fe(VI)) treatment technology.
Despite the high efficiency of residue removal using these methods, up to 90%, intermediate compounds were detected, formed by oxidation of the pharmaceutical products, which are more toxic than the pharmaceutical pollutants themselves (Richards & Cole ) . Richards and Cole studied the toxic response of frog embryos to different concentrations of ibuprofen via the Frog Embryo Teratogenesis Assay -Xenopus (FETAX) (Sigma-Aldrich, Canada). The results showed inhibition in embryo growth at concentrations of 30 mg/L after 96 h of exposure. Based on the toxicity test results (Quero-Pastor et al. ) with Selenastrum capricornium, the compound released during ozonation was more toxic than the parent compound.
Ibuprofen (Ibu), or 2-(4-isobutyl phenyl) propionic acid, is the first of the non-steroidal anti-inflammatory drugs (NSAIDs) derived from propionic acid, which is sold in many countries. It is important to emphasize that in 2005 this drug took 17th place on the list of the most commonly prescribed medications in the United States (Richards & Cole ) or 2,300 t/year. Studies were also performed in countries such as Germany, Spain, Switzerland, France, Italy, Sweden, Canada and Denmark, where quantifications of Ibu in wastewater effluents varied from 60 to 3,400 ng/L (Farré et al. ) . In numerous studies, the analysis of concentrations of pharmaceuticals found in surface waters detected concentrations of ibuprofen from 0.05 to 0.28 mg/L (Heberer & Stan ) . Considering all of these facts, it is vital to develop a process with more significant potential to remove pharmaceutical residues. Ibuprofen is one of the pharmaceuticals whose possibility of removal has been investigated by various methods. However, some of its metabolites have been detected in the effluent of a primary wastewater treatment plant at concentrations greater than 500 ng/L (Gagnon & Lajeunesse ) . One of the possible methods of pharmaceuticals and Ibu removal from aqueous environments is the application of ferrate(VI), an environmentally friendly oxidant, coagulant and disinfectant (Jiang ) . Ferrate(VI) is proven to be very efficient in a variety of application areas because of its suitable physical and chemical properties, such as: high oxidation potential of 2.2 V in acidic conditions and 0.7 V in alkaline conditions, forming of oxygen from water oxidation, and high capacity for coagulation of iron(III) hydroxide as a product of ferrate(VI) reduction (Sharma ) . Ferrate(VI) can be produced by chemical or electrochemical synthesis. Ferrate(VI) produced by electrochemical synthesis has many advantages compared with chemically synthesized ferrate(VI) (Macova et al. ; Nikolić-Bujanović et al. 2012) , such as: simplicity, lower consumption of chemicals, non-toxic products and exceptional purity of obtained ferrate(VI). Moreover, the electrochemically produced ferrate(VI) has no instability problem and needs no transportation, and because of ecological advantages it can be implemented in wastewater treatment practice, in situ.
Kinetic studies of ibuprofen oxidation by ferrate(VI) (Sharma & Mishra ) in the function of pH show the applicability of ferrate(VI) in the process of Ibu removal from water, which follows a first-order reaction with respect to each reactant. Recent research into ferrate(VI) application, in the process of micropollutant removal from an aqueous medium, has shown drug removal efficiency of over 85%, whereas for ibuprofen the efficiency was 40% (Jiang et al. ) . Also, the intermediate formed during the process of ibuprofen removal is non-toxic to living organisms in the water (Cеkеrеvаc et al. ).
The purpose of this paper is to contribute to the research into electrochemically synthesized ferrate(VI) application in the process of removing residues of pharmaceuticals, for example ibuprofen, as a secondary or primary process in conventional water treatment methods. Ferrate(VI), produced by a useful and environmentally friendly electrochemical process of synthesis, allows in situ application. This paper provides information which may be useful in defining the optimum conditions of Ibu treatment by ferrate(VI) with the aim of minimizing the concentration of Ibu as determined by chemical oxygen demand (COD) and total organic carbon (TOC).
EXPERIMENTAL WORK Materials and methods
The certified analytical grade pharmaceutical Ibu was purchased from Sigma-Aldrich, St Louis, Missouri, USA. An initial solution of ibuprofen was prepared at a concentration of 206 mg/L in 0.1 M phosphate buffer solution (K 2 HPO 4 / KH 2 PO 4 ) at pH ¼ 9, because it is the easiest way to maintain the desired pH of the solution in which the solubility of Ibu is the highest. The concentration of Ibu was chosen due to selectivity of the measuring methods, while the objective of the paper, to show the possibilities of Ibu removal by electrochemically synthesized ferrate(VI), is achieved. The sodium ferrate (Na 2 FeO 4 ) solution, a concentration of 6 g/L used for the treatment of Ibu, was electrochemically synthesized. The process of electrochemical synthesis of the alkaline solution of ferrate(VI) was based on transpassive anodic dissolution of iron alloys in a 10 M NaOH solution, in accordance with previous studies (Čеkеrеvаc et al. ; Nikolić-Bujanović et al. 2012) . This was carried out in a laboratory facility for electrochemical synthesis of ferrate(VI) (Figure 1) , which consists of a two-part flow-through electrochemical cell (Figure 2) .
The anode of the electrochemical cell is made of an iron alloy with content of: silica 1.6-6.0% (w/w), carbon up to 0.1% (w/w), manganese up to 0.1% (w/w), and copper, sulfur and aluminum at the level of impurities. The cathode is made of stainless steel AISI 304 in the form of a sheet with content of: chrome 18% (w/w) and nickel 10.5% (w/w). The process of anodic dissolution was carried out for a period of 3 h using an electric current of 2.5 A (j ¼ 85 mA/cm 2 ) at the temperature of 35 W C, whereby the solution Na 2 FeO 4 in a concentration of 6 g/L was obtained. The concentration of synthesized ferrate(VI) is controlled using the visible absorption spectrum (Rush & Bielski ) at a wavelength of 510 nm and the molar absorptivity (ε 510nm ) of ferrate(VI) in a solution of 1,150 ± 25 M À1 cm À1 at the temperature of 25 W C. The synthesis efficiency was 78%, compared with the theoretical value. Freshly synthesized ferrate(VI) was used for the treatment of 1 mM solution of ibuprofen. The treatment of Ibu samples with different concentrations of ferrate(VI) was carried out using a jar test with a four-unit stirrer (Velp JLT4).
The change in the concentration of Ibu was monitored using a UV-Vis spectrophotometer (Shimadzu UV 1800, Shimadzu, Japan) at a wavelength of 264 nm and calibration curves. The extent of mineralization was estimated using COD determinations following the titrimetric method, according to Standard Methods (APHA ), and TOC, total carbon (TC) and inorganic carbon (IC) were measured on a Shimadzu TOC-VCPH/CPN apparatus (Shimadzu, Japan).
Procedure
The stock solution of Ibu in 0.1 M phosphate buffer solution has the characteristics shown in Table 1 . After determination of the physical and chemical characteristics of the solution, 50 mL samples of Ibu solution were treated with freshly synthesized Na 2 FeO 4 at a concentration of 6 g/L, in ratios Ibu: Na 2 FeO 4 ¼ 1:1, 1:3, 1:6, 1:9 (m/m). The samples were treated at room temperature (25 W C), with an 190.9 ± 5 initial pH ¼ 9, stirred for 5 min using the Jar test at the speed of 300 rpm and for 20 min at the speed of 40 rpm, and then precipitated for 60 min. The treated samples were then filtered through a ceramic vacuum filter with the pore size of 0.20 μm. After filtration, the treated samples, with a pH ¼ 13, had their pH adjusted to the value of 6-7 by adding 1 M sulfuric acid (H 2 SO 4 ).
The changes in Ibu concentration treated by ferrate(VI) were determined by analyzing treated samples using a UV-Vis spectrophotometer at a wavelength of 264 nm. For each treated sample, values of COD, TOC, TC and IC were also determined.
RESULTS AND DISCUSSION
The Ibu solution in the concentration of 206 mg/L in 0.1 M phosphate buffer solution treated by an electrochemically synthesized fresh solution of Na 2 FeO 4 , concentration 6 g/L, at various concentrations of ferrate(VI) of 206, 618, 1,236, 1,854 mg/L has shown a tendency of decreasing Ibu concentration with increasing concentration of ferrate(VI).
Based on literature data (Zhou & Jiang ) , the Ibu solution has two peaks (264 and 272 nm), which has been demonstrated in our experiment. For the determination of Ibu, the peak at 264 nm was selected. The concentration of Ibu present in each sample was calculated by determining the value of absorbance for each sample at the peak of 264 nm (Figure 3) and by using the calibration curve ( Figure 4) . The results of reduction of Ibu concentration in proportion to the added doses of ferrate(VI) as Fe are shown in Figure 5 . The largest reduction of Ibu concentration, 86 mg/L (41.75%), was obtained by adding 69.2 mg/l ferrate(VI) as Fe. Further increase of the ferrate(VI) doses shows a smaller percentage of reduction with the tendency of less and less change in the concentration of Ibu. The maximum achieved reduction of Ibu concentration, compared with the initial concentration, was 140 mg/L (68%) obtained by adding 623 mg/L of ferrate(VI) as Fe.
The possibility of Ibu removal using ferrate(VI) was additionally confirmed by determining the value of COD and TOC in the Ibu solution treated by ferrate(VI) (Figures 6  and 7) . After the addition of 623 mg/L ferrate(VI) as Fe into the solution with the initial concentration of Ibu of 206 mg/L, the initial COD value of 615.8 mgO 2 /L and the initial TOC value of 190.9 mgC/L, there was a COD reduction of 65% and a TOC reduction of 63.6%.
The process of removing Ibu from an aqueous medium with ferrate(VI) has some limitations. The results indicate that the maximum percentage removal is achieved at a ratio of 1:1 (Ibu: ferrate(VI)). Any further increase in the amount of added ferrate(VI) has far less effect on Ibu removal. According to the results of TOC, IC, and TC analysis, it could be seen that the reaction of ferrate(VI) with Ibu provides various products, while a low percentage of IC indicates that one part of Ibu is oxidized to CO 2 but one part is lost in the atmosphere. The oxidation products of Ibu are 4-acetylbenzoic acid, oxoibuprofen and 4-IBAP (Caviglioli et al. ; Sabri et al. ) . Also, it is likely that one part of Ibu is removed by flocculation and coagulation with ferrous hydroxide, which is obtained as a product of ferrate(VI) reduction and has a very developed absorption area (Jiang & Lloyd ) . Since ferrous hydroxide has an extremely low solubility in these conditions, the presence of residual Fe is not expected. The explanation of the weak reactivity of Ibu with ferrate(VI) lies in the fact that the carboxyl group of Ibu is an electron-withdrawing functional group, which can depress the reaction of the aromatic ring with ferrate(VI) (Yang et al. ) . Therefore, the reactivity of ferrate(VI) with carboxylic acids is usually low; the rate constant for Ibu is only 0.09 M À1 s À1 at pH ¼ 8 (Sharma & Mishra ) . Faster reaction rates of the protonated and ionized forms of ferrate(VI) are responsible for an increase in oxidation rates of Ibu by ferrate(VI). Ionized forms, FeO 2À 4 , are the dominant species in alkaline conditions, and protonated forms, HFeO À 4 , predominate in mildly acidic conditions. Even though the oxidation potential of ferrate(VI) in acidic conditions (2.2 V) is higher than the oxidation potential in an alkaline medium (0.76 V), the treatment of Ibu removal from an aqueous solution was performed at pH ¼ 9 due to higher stability of ferrate(VI) and higher efficiency of oxidation and coagulation processes of ferrate(VI) in an alkaline medium. After wastewater treatment by ferrate(VI), neutralization of the solution to pH ¼ 7 is carried out by an acid.
The treatment of Ibu with in situ electrochemically synthesized ferrate(VI) deserves attention and further optimization due to the favorable environmental and economic characteristics of the process of synthesis ( Jiang et al. ) . Also, the use of electrochemically synthesized ferrate(VI) in wastewater treatment reduces the number of required chemicals, transport costs and the amount of generated sludge.
The most important advantage of in situ Ibu treatment by ferrate(VI) in contrast to other oxidizing agents is the demonstrated non-toxicity of waste intermediates and byproducts formed in the reaction of oxidation of Ibu by ferrate(VI) (Jiang et al. ) .
CONCLUSION
The aim of this study was to examine the possibilities of Ibu removal from aqueous solutions in the reaction of oxidation by freshly electrochemically synthesized ferrate(VI) with environmentally friendly non-toxic intermediates as the final products of oxidation. Both mortality of zebrafish embryo tests and microscopic images clearly demonstrated that raw wastewater effluents possessed toxicity to zebrafish but ferrate(VI) treated effluents had no adverse effects (Jiang et al. ) . This finding will encourage the implementation of ferrate(VI) in the treatment of pharmaceutical-containing wastewater.
Because of the non-toxicity of ferrate(VI) and its products, the aim of the paper was to find the conditions for the treatment of Ibu by ferrate(VI). Ibu was chosen because of its heavy removal from wastewater by conventional methods and conventional plants for wastewater treatment, as well as formation of toxic products when other oxidation agents are used. Previous studies have shown the removal efficiency of Ibu by ferrate(VI) to be about 50% (Jiang et al. ) .
It has been shown that the effective removal of Ibu by ferrate(VI) in aqueous solutions can be possible up to 68% by using ferrate(VI) in the ratio Ibu: Fe ¼ 1:3 as Fe. The possibility of Ibu removal by ferrate(VI) was also confirmed by the results of COD and TOC, which have demonstrated removal of up to 65% and 63.6%, respectively. Decreased effectiveness of ferrate(VI) in the process of Ibu removal can be explained by low reactivity of ferrate(VI) with the carboxylic group, an electron-withdrawing functional group which hinders the reaction of ferrate(VI) with the aromatic ring of Ibu.
